Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06033378

Blood Pressure Treatment in ICU Patients with Subarachniodal Haemorrhage - Can Blood Pressure Be Used As a Surrogate Marker for Blood Flow

Led by Umeå University · Updated on 2025-03-13

30

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

U

Umeå University

Lead Sponsor

R

Region Västerbotten

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research investigates how blood pressure changes affect cerebral blood flow in patients who have had a subarachnoid hemorrhage (SAH), a serious type of stroke often requiring intensive care. The study focuses on patients with suspected or confirmed vasospasm, a complication that can occur days after the initial hemorrhage and impacts brain blood flow. Researchers aim to understand the relationship between blood pressure and brain nourishment during this critical period. Participants will undergo a process where blood pressure is increased by about 20-30% from their baseline using medication called norepinephrine while in the neuro-intensive care unit. Magnetic resonance imaging (MRI) techniques, including phase-contrast MRI and arterial spin labeling, will be used to measure cerebral blood flow before and after the blood pressure change. Blood pressure levels will be kept within safe clinical limits throughout the procedure. During the study, participants will have MRI scans to assess blood flow at baseline and after blood pressure elevation. All data will be recorded in the patients' medical records and analyzed later. The main outcome measured is cerebral blood flow within one hour of the intervention. The study is led by Umeå University and includes ongoing monitoring to ensure safety and accurate data collection during neuro-intensive care treatment.

CONDITIONS

Brief Title

Blood Pressure Treatment in ICU Patients with Subarachniodal Haemorrhage.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Coiled or clipped aneurysm
  • Suspected or confirmed vasospasm
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • Body mass index (BMI) greater than 30
  • Pregnancy
  • Pacemaker or other contraindications to MRI
  • Severe congestive heart failure (NYHA III-IV) or cardiac arrhythmia
  • Severe respiratory failure or requiring FiO2 greater than 0.6
  • Severe kidney failure

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (in-person)

Treatment

Duration - Approximately 1 hour

Participants receive blood pressure elevation using medications to measure changes in cerebral blood flow using MRI imaging.

1 treatment visit involving MRI imaging and blood pressure manipulation

Trial Site Locations

Total: 1 location

1

Umeå University Hospital

Umeå, Sweden

Actively Recruiting

Loading map...

Research Team

L

Laleh Zarrinkoob, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Similar Trials

Pilot Study of 3D Ultrasound Localization Microscopy to Dete...

Subarachnoid Hemorrhage

Actively Recruiting

1 location

PhytoRx Families: A Pilot Test Study to Address Food Securit...

Diet, Healthy

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Study protocol: MRI-based assessment of cerebral blood flow under pharmacologically elevated blood pressure in patients under general anesthesia, and in sedated ICU patients with aneurysmal subarachnoid hemorrhage.

Jonas Österlind, Johan Birnefeld, Elin Birnefeld...

https://pubmed.ncbi.nlm.nih.gov/41370289